Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodiesNature Medicine, 2022-06, Vol.28 (6), p.1297-1302 [Peer Reviewed Journal]2022. The Author(s), under exclusive licence to Springer Nature America, Inc. ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2022. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1078-8956 ;EISSN: 1546-170X ;EISSN: 1744-7933 ;DOI: 10.1038/s41591-022-01792-5 ;PMID: 35322239Full text available |
|
2 |
Material Type: Article
|
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfectionEBioMedicine, 2021-09, Vol.71, p.103561-103561, Article 103561 [Peer Reviewed Journal]2021 The Author(s) ;Attribution - NonCommercial - NoDerivatives ;2021 The Author(s) 2021 ;ISSN: 2352-3964 ;EISSN: 2352-3964 ;DOI: 10.1016/j.ebiom.2021.103561 ;PMID: 34455390Full text available |
|
3 |
Material Type: Article
|
LILAC pilot study: Effects of metformin on mTOR activation and HIV reservoir persistence during antiretroviral therapyEBioMedicine, 2021-03, Vol.65, p.103270-103270, Article 103270 [Peer Reviewed Journal]2021 The Author(s) ;Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved. ;2021 The Author(s) 2021 ;ISSN: 2352-3964 ;EISSN: 2352-3964 ;DOI: 10.1016/j.ebiom.2021.103270 ;PMID: 33662832Full text available |
|
4 |
Material Type: Article
|
Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective studyEBioMedicine, 2021-11, Vol.73, p.103637-103637, Article 103637 [Peer Reviewed Journal]2021 The Authors ;Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved. ;Attribution - NonCommercial - NoDerivatives ;2021 The Authors 2021 ;ISSN: 2352-3964 ;EISSN: 2352-3964 ;DOI: 10.1016/j.ebiom.2021.103637 ;PMID: 34678613Full text available |
|
5 |
Material Type: Article
|
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2EBioMedicine, 2022-03, Vol.77, p.103934-103934, Article 103934 [Peer Reviewed Journal]2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved. ;Attribution - NonCommercial - NoDerivatives ;2022 The Author(s) 2022 ;ISSN: 2352-3964 ;EISSN: 2352-3964 ;DOI: 10.1016/j.ebiom.2022.103934 ;PMID: 35290827Full text available |
|
6 |
Material Type: Article
|
A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populationsScience Translational Medicine, 2020-09, Vol.12 (559) [Peer Reviewed Journal]2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;ISSN: 1946-6234 ;EISSN: 1946-6242 ;DOI: 10.1126/scitranslmed.abc3103 ;PMID: 32817357Digital Resources/Online E-Resources |
|
7 |
Material Type: Article
|
HIV-1 selectively targets gut-homing CCR6+CD4+ T cells via mTOR-dependent mechanismsJCI insight, 2017-08, Vol.2 (15) [Peer Reviewed Journal]Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2017, American Society for Clinical Investigation 2017 American Society for Clinical Investigation ;ISSN: 2379-3708 ;EISSN: 2379-3708 ;DOI: 10.1172/jci.insight.93230 ;PMID: 28768913Full text available |
|
8 |
Material Type: Article
|
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodiesCell reports. Medicine, 2022-12, Vol.3 (12), p.100850-100850, Article 100850 [Peer Reviewed Journal]2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;Attribution - NonCommercial - NoDerivatives ;2022 The Author(s) 2022 ;ISSN: 2666-3791 ;EISSN: 2666-3791 ;DOI: 10.1016/j.xcrm.2022.100850 ;PMID: 36450283Full text available |